Oxygen deprivation followed by reoxygenation causes pathological responses in many disorders, including ischemic stroke, heart attacks, and reperfusion injury. Key aspects of ischemia-reperfusion can be modeled by a Caenorhabditis elegans behavior, the O2-ON response, which is suppressed by hypoxic preconditioning or inactivation of the O 2 -sensing HIF (hypoxia-inducible factor) hydroxylase EGL-9. From a genetic screen, we found that the cytochrome P450 oxygenase CYP-13A12 acts in response to the EGL-9-HIF-1 pathway to facilitate the O2-ON response. CYP-13A12 promotes oxidation of polyunsaturated fatty acids into eicosanoids, signaling molecules that can strongly affect inflammatory pain and ischemia-reperfusion injury responses in mammals. We propose that roles of the EGL-9-HIF-1 pathway and cytochrome P450 in controlling responses to reoxygenation after anoxia are evolutionarily conserved.
I schemia-reperfusion-related disorders, such as strokes and heart attacks, are the most common causes of adult deaths worldwide (1) . Blood delivers O 2 and nutrients to target tissues, and ischemia results when the blood supply is interrupted. The restoration of O 2 from blood flow after ischemia, known as reperfusion, can exacerbate tissue damage (2) . How organisms prevent ischemia-reperfusion injury is poorly understood. Studies of the nematode C. elegans led to the discovery of an evolutionarily conserved family of O 2 -dependent enzymes (EGL-9 in C. elegans and EGLN2 in mammals) that hydroxylate the HIF transcription factor and link hypoxia to hypoxiainducible factor (HIF)-mediated physiological responses (3) (4) (5) (6) (7) . Exposure to chronic low concentrations of O 2 (hypoxic preconditioning) or direct inhibition of EGLN2 strongly protects mammals from stroke and ischemia-reperfusion injury (2, 8, 9) . Similarly, EGL-9 inactivation in C. elegans blocks a behavioral response to reoxygenation, the O2-ON response (characterized by a rapidly increased locomotion speed triggered by reoxygenation after anoxia) (10, 11) , which is similar to mammalian tissue responses to ischemiareperfusion: (i) Reoxygenation drives the O2-ON response and is the major pathological driver of reperfusion injury, (ii) hypoxic preconditioning can suppress both processes, and (iii) the central regulators (EGL-9-HIF) of both processes are evolutionarily conserved. It remains unknown how the EGL-9-HIF-1 and EGLN2-HIF pathways control the O2-ON response and ischemiareperfusion injury, respectively.
To seek EGL-9-HIF-1 effectors important in the O2-ON response, we performed an egl-9 suppressor screen for mutations that can restore the defective O2-ON response in egl-9 mutants (fig. S1A). We identified new alleles of hif-1 in this screen; because EGL-9 inhibits HIF-1, hif-1 mutations suppress the effects of egl-9 mutations (10) . We also identified mutations that are not alleles of hif-1 (Fig. 1 , A to C, and fig. S1B). hif-1 mutations recessively suppressed three defects of egl-9 mutants: the defective O2-ON response, defects in egg laying, and the ectopic expression of the HIF-1 target gene cysl-2 (previously called K10H10.2) (fig. S1C) (10, 12) . By contrast, one mutation, n5590, dominantly suppressed the O2-ON defect but did not suppress the egg-laying defect or the ectopic expression of cysl-2::GFP (Fig. 1, D and E, and fig. S2 ). n5590 restored the sustained phase (starting 30 s after reoxygenation) better than it did the initial phase (within 30 s after reoxygenation) (Fig. 1 , A to C). egl-9; hif-1; n5590 triple mutants displayed a normal O2-ON response, just like the wild type and egl-9; hif-1 double mutants ( fig.  S1D ). Thus, n5590 specifically suppresses the egl-9 defect in the sustained phase of the O2-ON response.
We genetically mapped n5590 and identified a Met 46 → Ile missense mutation in the gene cyp-13A12 by whole-genome sequencing ( Fig.  2A, fig. S3A , and table S1A). Decreased wildtype cyp-13A12 gene dosage in animals heterozygous for a wild-type allele and the splice acceptor null mutation gk733685, which truncates the majority of the protein, did not recapitulate the dominant effect of n5590 (Fig. 2B) . Similarly, gk733685 homozygous mutants did not recapitulate the effect of n5590 (Fig. 2C) . Thus, n5590 does not cause a loss of gene function. By contrast, increasing wild-type cyp-13A12 gene dosage by overexpression restored the sustained phase of the O2-ON response (Fig. 2D) , and RNA interference (RNAi) against cyp-13A12 abolished the effect of n5590 (Fig. 2E) . We conclude that n5590 is a gain-of-function allele of cyp-13A12.
cyp-13A12 encodes a cytochrome P450 oxygenase (CYP). CYPs can oxidize diverse substrates (13) (14) (15) . The C. elegans genome contains about 82 CYP genes, at least two of which are polyunsaturated fatty acid (PUFA) oxygenases that generate eicosanoid signaling molecules ( fig.  S3B) (16, 17) . On the basis of BLASTP scores, the closest human homolog of CYP-13A12 is CYP3A4 ( fig. S4) . We aligned the protein sequences of CYP-13A12 and CYP3A4 and found that n5590 converts methionine 46 to an isoleucine, the residue in the corresponding position of normal human CYP3A4 ( fig. S4 ). Methionines can be oxidized by free radicals, which are produced in the CYP enzymatic cycle, rendering CYPs prone to degradation (18, 19) . Using transcriptional and translational green fluorescent protein (GFP)-based reporters, we identified the pharyngeal marginal cells as the major site of expression of cyp-13A12 ( fig. S5 ) and observed that the abundance of CYP-13A12::GFP protein was decreased by prolonged hypoxic preconditioning and also decreased in egl-9 but not in egl-9; hif-1 mutants (Fig. 2F and fig. S5 ). The n5590 mutation prevented the decrease in CYP-13A12::GFP abundance by hypoxia or egl-9. Thus, n5590 acts, at least in part, by restoring the normal abundance of CYP-13A12, which then promotes the O2-ON response in egl-9 mutants.
We tested whether CYP-13A12 was normally required for the O2-ON response in wild-type animals. The cyp-13A12 null allele gk733685 abolished the sustained phase of the O2-ON response; the initial phase of the O2-ON response was unaffected (Fig. 3A) . Awild-type cyp-13A12 transgene fully rescued this defect (Fig. 3B) . A primary role of CYP-13A12 in the sustained phase of the O2-ON response explains the incomplete rescue of the defective O2-ON response of egl-9 mutants by n5590 during the initial phase (Fig. 1C) . The activity of most and possibly all C. elegans CYPs requires EMB-8, a CYP reductase that transfers electrons to CYPs (20) . No non-CYP EMB-8 targets are known. The mutation emb-8(hc69) causes a temperature-sensitive embryonic lethal phenotype. We grew emb-8(hc69) mutants at the permissive temperature to the young-adult stage. A shift to the nonpermissive temperature simultaneously with Escherichia coli-feeding RNAi against emb-8 nearly abolished the O2-ON response (Fig. 3, C and D) .
[Both the hc69 mutation and RNAi against emb-8 were required to substantially reduce the level of EMB-8 (17) .] CYP-13A12 is thus required for the sustained phase of the O2-ON response, and one or more other CYPs likely act with CYP-13A12 to control both phases of the O2-ON response.
CYP oxygenases define one of three enzyme families that can convert PUFAs to eicosanoids, which are signaling molecules that affect inflam-matory pain and ischemia-reperfusion responses of mammals (15, (21) (22) (23) ; the other two families, cyclooxygenases and lipoxygenases, do not appear to be present in C. elegans (17, 24) . To test whether eicosanoids are regulated by EGL-9 and CYP-13A12, we used high-performance liquid chromatography (HPLC) coupled with mass spectrometry (MS) to profile steady-state amounts of 21 endogenous eicosanoid species from cell extracts of wild-type, egl-9(n586), and egl-9(n586); cyp-13A12(n5590) strains. Only free eicosanoids have potential signaling roles (21, 22, 24) , so we focused on free eicosanoids. The egl-9 mutation caused a marked decrease in the overall amount of free eicosanoids, whereas the total amount of eicosanoids, including both free and membranebound fractions, was unaltered ( Fig. 4A and fig.  S6 ). Among the eicosanoids profiled, 17,18-DiHEQ (17,18-diolhydroxyeicosatetraenoic acid) was the most abundant species (fig. S6B ). 17,18-DiHEQ is the catabolic hydrolase product of 17,18-EEQ (17,18-epoxyeicosatetraenoic acid), an epoxide active in eicosanoid signaling (25) . Free cytosolic 17,18-EEQ and 19-hydroxyeicosatetraenoic acid were present in the wild type but undetectable in egl-9 mutants (Fig. 4, C to F) . egl-9(n586); cyp-13A12(n5590) mutants exhibited partially restored free overall eicosanoid levels as well as restored levels of 17,18-EEQ and 19-HETE (Fig. 4, A to F, and fig. S6B ). Thus, both EGL-9 and CYP-13A12 regulate amounts of free cytosolic eicosanoids.
We tested whether the O2-ON response requires PUFAs, which are CYP substrates and eicosanoid precursors. PUFA-deficient fat-2 and fat-3 mutants (26) exhibited a complete lack of the O2-ON response, although the acceleration in response to anoxia preceding the O2-ON response was normal (Fig. 4G and fig. S7 , A to C). The defective O2-ON response of fat-2 mutants was restored by feeding animals arachidonic acid, a C20 PUFA (Fig. 4H) , but not oleate, a C18 monounsaturated fatty acid that is processed by FAT-2 to generate C20 PUFAs ( fig. S7D ). These results demonstrate an essential role of PUFAs for the O2-ON response.
We suggest a model in which CYPs, which are strictly O 2 -dependent (27, 28) , generate eicosanoids to drive the O2-ON response (Fig. 4I  and fig. S8 ). In this model, EGL-9 acts as a chronic O 2 sensor, so that during hypoxic preconditioning, the O 2 -dependent activity of EGL-9 is inhibited, HIF-1 is activated, and unknown HIF-1 up-regulated targets decrease CYP protein abundance. The low abundance of CYPs defines the hypoxic preconditioned state. Without hypoxic preconditioning, CYPs generate eicosanoids, which drive the O2-ON response. By contrast, with hypoxic preconditioning or in egl-9 mutants, the CYP amounts are insufficient to generate eicosanoids and the O2-ON response is not triggered. Neither C20 PUFAs nor overexpression of CYP-29A3 restored the defective O2-ON response of egl-9 mutants (figs. S9 and S10), indicating that this defect is unlikely to be caused by a general deficiency in C20 PUFAs or CYPs. Because the O2-ON response requires EMB-8, a general CYP reductase, but only the sustained phase requires CYP-13A12, we propose 
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2 AUGUST 2013 VOL 341 SCIENCE www.sciencemag.org that CYP-13A12 and other CYPs act as acute O 2 sensors and produce eicosanoids, which are short-lived and act locally (22) during reoxygenation to signal nearby sensory circuits that drive the O2-ON response.
In humans, a low uptake of PUFAs or an imbalanced ratio of w3-to-w6 PUFAs is associated with elevated risk of stroke, cardiovascular disease, and cancer (21, 23, 29, 30) . Cytochrome P450s and eicosanoid production also have been implicated in mammalian ischemia-reperfusion (15, 21) . Nonetheless, little is known concerning the causal relationships among and mechanisms relating O 2 and PUFA homeostasis, CYP, and PUFA-mediated cell signaling and organismal susceptibility to oxidative disorders. Our results identify a pathway in which EGL-9-HIF-1 regulates CYP-eicosanoid signaling, demonstrate that PUFAs confer a rapid response to reoxygenation via CYP-generated eicosanoids, and provide direct causal links among CYPs, PUFA-derived eicosanoids, and an animal behavioral response to reoxygenation. Because the molecular mechanisms of O 2 and PUFA homeostasis are fundamentally similar and evolutionarily conserved between nematodes and mammals (7, 11, 26) , we suggest that the C. elegans O2-ON response is analogous to the mammalian tissue and cellular response to ischemia-reperfusion injury and that the molecular pathway including EGL-9-HIF-1 and CYPs in controlling responses to reoxygenation after anoxia is evolutionarily conserved. Robust transmission of information despite the presence of variation is a fundamental problem in cellular functions. However, the capability and characteristics of information transmission in signaling pathways remain poorly understood. We describe robustness and compensation of information transmission of signaling pathways at the cell population level. We calculated the mutual information transmitted through signaling pathways for the growth factor-mediated gene expression. Growth factors appeared to carry only information sufficient for a binary decision. Information transmission was generally more robust than average signal intensity despite pharmacological perturbations, and compensation of information transmission occurred. Information transmission to the biological output of neurite extension appeared robust. Cells may use information entropy as information so that messages can be robustly transmitted despite variation in molecular activities among individual cells.
S
ignaling pathways transmit signals from growth factors to downstream gene expression, influencing various cell fate decisions such as cell differentiation (1) . To control cellular responses by stimulation intensity, signaling pathways must reliably transmit stimulation intensity through their signaling activities. The reliability of signal transmission depends on the balance between signal intensity and variation. The smaller the signal variation, the more information can be transmitted through a pathway with the same dynamic range of signal intensity. Even high-intensity signals cannot be reliably transmitted if the variation in signal intensity is large. In contrast, even signals with low intensity can be reliably transmitted if the variation in signal intensity is small (Fig. 1A) . Thus, the reliability of signal transmission depends on both average (mean) intensity and variation. As a consequence, the number of controllable states of cellular responses is determined by the number of reliably transmitted signals. Intuitively, the larger the number of reliably transmitted signals, the more information the signal pathway can transmit. If cellular signaling pathways are treated as communication channels in the framework of Shannon's information theory (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , the amount of information that can be reliably transmitted through a cellular signaling pathway can be measured by mutual information, which corresponds to the logarithm of the average number of controllable states of a cellular response that can be defined by varied upstream signals (13) (14) (15) 
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Figs. S1 to S11 we used a nitrogen gas-flow chamber system with a 100% nitrogen gas source, flowmeters, and a lid with gas tubing inlets and outlets mounted on a Petri plate freshly seeded with E. coli OP50 (10). Animals with restored rapid acceleration immediately (0 -60s) after reoxygenation (by removal of the plate lid) were identified as suppressors of the defective O2-ON response. False positives were eliminated by retesting animals in the next generation using a population assay (>50 animals) (10).
To map the egl-9 suppressor mutation n5590, we first generated a polymorphic
Hawaiian egl-9(n586) strain by repeatedly crossing egl-9(n586) with the Hawaiian wildtype strain CB4856. nIs470; egl-9(n586); n5590 mutants were then crossed with the Hawaiian egl-9(n586) strain for genetic mapping. F2 animals were isolated, and clonal F3 populations were assayed for the O2-ON response. Mapping using SNP analysis (50) positioned n5590 between the SNPs pkP3075 and uCE3-1426 on chromosome III ( Fig.   2A ).
Whole-genome sequencing and data analyses were performed as described (51) .
Two protein-coding mutations were identified in the n5590 interval defined above: a Tto-G mutation in the gene Y39E4A.2 and a G-to-A mutation in the gene cyp-13A12. As described in the text, we showed that the egl-9 suppressor n5590 is a gain-of-function mutation of cyp-13A12.
Behavioral Analyses
The O2-ON response was measured using a multi-worm tracker with a gas-flow chamber system and quantified by customized MatLab algorithms as previously described (10) . For experiments using the C20 PUFA arachidonic acid as a food supplement, arachidonic acid salts (Cayman Chemical) were dissolved in ethanol at 1 mg/ml, and 50 µL was spread evenly onto NGM plates before drying briefly and cultivating OP50 E. coli on the plates. C. elegans was then transferred to the PUFAsupplemented plates.
To quantify egg-laying behavior, we scored the developmental stages of newly laid eggs of young adult hermaphrodites that had been transferred to fresh NGM plates with OP50 (52).
Determination of eicosanoid levels
Endogenous CYP-derived eicosanoids were assayed for the N2 wild-type strain as well as for egl-9(n586) and egl-9(n586); cyp-13A12(n5590) mutant strains. For each experiment (three independent cultures per strain), 12,000 stage-synchronized larvae were allocated to four fresh Petri plates (diameter = 94 mm) and further cultivated at 22.5°C until the young adult stage (24 hrs post-L4). To generate a synchronous culture of first-stage (L1) larvae, a population of well-fed animals was collected from Petri plates by rinsing and then filtered through a 10 µm membrane (SM 16510/11, Sartorius, Goettingen, Germany), a pore size that retains all but L1 larvae. These larvae were allowed to grow to be young adults and then were filtered again to eliminate L1 larvae of the next generation and so retain exclusively young adults. Subsequently, animals were prepared for LC-MS/MS analysis essentially as described previously (17) . Briefly, aliquots corresponding to 30 mg wet weight were mixed with internal standard compounds (10 ng each of 20-HETE-d6, 14,15-EET-d8 and 14,15-DHET-d11; from Cayman Chemicals, Ann Arbor, MI, USA) and either subjected to alkaline hydrolysis (total eicosanoids) or directly extracted with methanol/water (free eicosanoids) followed by solid-phase extraction of the metabolites. Sample preparation, HPLC and MS conditions as well as the monitoring of multiple reactions for the analysis of the CYPeicosanoid profile were as described previously (25) . The protein concentration of each sample was measured after hydrolysis (53).
Mutations and Strains
C. elegans strains were cultured as described previously (54) . The N2 Bristol strain (54) Transgenic strains were generated by germline transformation as described (61) . 
Molecular biology
Constructs were generated using the PCR-fusion technique (62), the Gateway system (Invitrogen) and the Infusion cloning (Clontech) technique (63) . Primer sequences are shown in Table S1 .
Statistical analyses
One-sided unpaired t-tests were used to compare the mean speeds of all animals within 60 or 120 seconds before or after O 2 restoration (10). p<0.01 indicates speed differences that are significant, as noted in each figure. Fisher's exact tests were used after egg-laying behavioral assays to compare the distributions of the six categories of embryos from the wild type and various mutants. Two-way ANOVA was used to
calculate p values to test for significance of the effects of genotypes and different conditions in the O2-ON response.
Bioinformatics
The BLASTP program from NCBI was used to search for proteins homologous to CYP-13A12 (64) . Multiple sequence alignments were generated and analyzed using ClusterW2 (65) , and the results were displayed and annotated using JalView (66).
Schematic gene structures and annotations were generated using the Exon-Intron Graphic Maker (http://wormweb.org/exonintron).
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Transcriptional and translational GFP reporters with the cyp-13A12 promoter or with the promoter and coding sequence were both most strongly expressed in the pharynx ( fig. S5 ). The GFP-stained pharyngeal cells extended processes along the anterior pharyngeal bulb and exhibited finger-like protrusions, and we identified these cells as the pharyngeal marginal cells (MCs). MCs intercalate with pharyngeal muscles and might structurally reinforce these muscles (31) . However, MCs contain abundant mitochondria, suggesting that these cells might perform active non-structural roles (32) . The O2-ON response involves rapid reoxygenation and occurs independently of known aerotaxic neural O 2 sensors (10, 11, (33) (34) (35) ; we hypothesize that MCs actively signal reoxygenation by converting PUFAs to membrane-diffusible eicosanoids, which are sensed by nearby sensory neurons and trigger the O2-ON response via neural circuits that control forward/backward locomotion (36, 37) .
In egl-9 mutants or animals with prolonged (24 hrs) hypoxic preconditioning (10), the O2-ON response is suppressed because CYP-13A12 is decreased through the EGL-9/HIF-1 pathway (Figs. 2F and 4J). Our GFP reporter experiments indicate that regulation of CYP-13A12 by EGL-9/HIF-1 occurs primarily by regulation of the abundance of CYP proteins (Fig. 2F and fig. S5 ). HIF-1 activation can facilitate protein ubiquitination and homeostasis and pro-survival effects of hypoxic preconditioning likely require suppression of protein translation in C. elegans (38) (39) (40) . We suggest that one or more transcriptional targets of HIF-1 regulate the abundance of CYP-13A12 and likely that of other CYPs, since CYP-13A12 does not control the initial phase but EMB-8, a general CYP reductase, affects both the initial and sustained phases (Fig. 3) . egl-9(n685);
cyp-13A12(n5590) mutants might have been restored for the sustained phase of the O2-ON response because they have restored the abundance of CYP-13A12 and thus partially restored the ability to produce eicosanoids from PUFAs. Because cdk-5 mutations suppress the defective LIN-10 trafficking in egl-9 mutants (41), we also tested cdk-5 mutants and found that cdk-5 mutations did not suppress cysl-2::GFP expression, the defective egg-laying behavior, or the defective O2-ON response or of egl-9 mutants (figs. S11A-S11B), indicating that EGL-9 regulates the O2-ON response independently of CDK-5.
Our conclusions are consistent with findings that mammalian CYP proteins closely related to C. elegans CYP13A12 are expressed in tissues that display ischemiareperfusion injury and are involved in eicosanoid signaling. For example, CYP3A4 is the most closely related human homolog of C. elegans CYP13A12 (162/501 or 32% amino acid identity with CYP13A12) and is mainly expressed in the liver but is also highly expressed in the brain (42) (43) (44) , consistent with our hypothesis that CYP3A4 modulates ischemic processes in these organs. We note that members of particular CYP protein families share high similarity in general, and CYP13A12 is also homologous to other mammalian CYPs, including the CYP5A1 thromboxane synthase (148/481 or 31% amino acid identity with CYP13A12), which generates the eicosanoid thromboxane and is widely expressed in the vasculature (45) , suggesting that CYP5A1-generated eicosanoids function in the vasculature. Increased production of HETE-type eicosanoids is also associated with ischemia-reperfusion processes (46, 47) . DAF-9), CYP-33E2 and CYP-29A3 as lipid hydroxylases are noted (16, 17, 68, 69) . 
fig. S4. Similarity between C. elegans CYP-13A12 and human CYP3A4 proteins
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(A) Protein-coding mutations within the genetically mapped interval identified by whole-genome sequencing of the n5590 mutant. These mutations seen after EMS mutagenesis were not present in the parental mutagenized strain. 
